Welcome to our dedicated page for Honeywell Intl SEC filings (Ticker: HON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Honeywell International Inc. (NASDAQ: HON), including current reports on Form 8-K and other key documents. These filings offer detailed information on Honeywell’s segment structure, portfolio actions, financing arrangements, governance changes and material events.
Honeywell’s recent 8-K filings describe several significant corporate developments. The company has reported on the completed spin-off of its Advanced Materials business into Solstice Advanced Materials Inc., which now trades separately on Nasdaq under the ticker SOLS, and on the planned separation of its global Aerospace Technologies business into an independent, publicly traded company. Other filings outline the realignment of Honeywell’s reportable segments into Aerospace Technologies, Building Automation, Process Automation and Technology, and Industrial Automation, with additional operations in Corporate and All Other.
Filings also detail capital markets activity and liability management. Honeywell lists multiple series of senior notes on Nasdaq, and its 8-Ks identify these securities and their terms. The company has disclosed the permanent divestiture of certain legacy asbestos liabilities through the sale of a subsidiary holding those liabilities and related insurance assets, and has described an agreement with Resideo Intermediate Holding Inc. to terminate an indemnification and reimbursement arrangement via a one-time cash payment, subject to closing conditions.
Through Stock Titan, users can monitor new Honeywell filings as they are posted to EDGAR and use AI-powered summaries to interpret complex documents such as Form 8-Ks, 10-K annual reports, 10-Q quarterly reports and proxy materials. The filings page is a central resource for understanding Honeywell’s regulatory disclosures, including segment realignments, spin-offs, leadership changes and significant agreements affecting HON shareholders and bondholders.
Honeywell International announced on August 21, 2025 that Solstice Advanced Materials, LLC, a wholly owned Honeywell subsidiary, filed a Form 10 with the SEC to convert into a Delaware corporation and be renamed Solstice Advanced Materials Inc. The Form 10 filing was made in connection with the anticipated spin-off of Honeywell's Advanced Materials business into an independent, publicly traded company. Honeywell furnished press releases as Exhibits 99.1 and 99.2: one announcing the Form 10 filing and the other disclosing the anticipated post-spin-off board composition for Solstice. The report states the furnished information is not "filed" under the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Honeywell International (HON) Form 144 filing discloses a planned sale of 3,448 common shares through Morgan Stanley Smith Barney on or about 01 Aug 2025. Based on the filer’s reference price, the transaction is valued at $752,026. The shares originate from recent restricted-stock vesting and option exercises under Honeywell’s equity-compensation plans. With 634.9 million shares outstanding, the proposed sale equals roughly 0.0005 % of total shares.
No sales have been reported in the past three months, and the signer certifies possession of no undisclosed adverse information, as required by Rule 144. Because Form 144 only signals intent, the sale may or may not be executed. Given the modest size relative to Honeywell’s float and average trading volumes, the filing appears to be routine insider activity with limited market impact.
Honeywell (HON) has signed an agreement to terminate its 2018 Indemnification and Reimbursement Agreement with Resideo. In exchange for cancelling all future variable payments (capped at $140 M per year through 2043), Resideo Intermediate Holding (RIH) will make a one-time cash payment of $1.59 B to Honeywell at closing, expected no later than 29 Aug 2025 (extension to 30 Oct 2025 at Honeywell’s option). A scheduled $35 M quarterly payment was already received on 29 Jul 2025.
From signing to closing, scheduled indemnity payments are suspended and, if closing occurs, permanently forgiven. If the deal fails to close and Honeywell terminates after 29 Aug 2025 (or Resideo after 30 Oct 2025), Resideo must pay a $100 M liquidated-damage fee and the original indemnity agreement remains in force with accrued interest (5% p.a.). Resideo and RIH represent that committed financing, plus cash on hand, will cover the payment; their obligations are not conditioned on funding.
Separately, Honeywell’s Board amended and restated the company By-laws on 25 Jul 2025, adding Article V, Section 17 to designate a Senior Management Official for U.S. National Industrial Security Program compliance.
Honeywell International (HON) President & CEO, BA division, Billal Hammoud reported insider activity for 28 Jul 2025.
- M code: 627 common shares were acquired through the conversion of vested restricted stock units (1-for-1).
- F code: 247 shares were concurrently sold at $226.24 to cover tax-withholding obligations.
The net effect is an increase of +380 shares. Hammoud now holds 4,198 shares directly and 303.1826 shares indirectly in the company 401(k) plan. The filing also notes 607 unvested RSUs scheduled to vest on 28 Jul 2026.
Because the transactions stem from routine equity-compensation vesting, involve fewer than 0.0001 % of Honeywell’s ~670 million diluted shares, and were not open-market buys/sells, the disclosure is unlikely to move the stock.